Mitochondrial haplogroups and control region polymorphisms are not associated with prostate cancer in Middle European caucasians

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Mueller, Edith E ^a   Eder, Waltraud ^a   Mayr, Johannes A ^a   Paulweber, Bernhard ^a   Sperl, Wolfgang ^a   Horninger, Wolfgang ^b   Klocker, Helmut ^b   Kofler, Barbara ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; PRIMER DNA;

AGED; ARTICLE; BASE PAIRING; CANCER SUSCEPTIBILITY; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLEASON SCORE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MIDDLE EUROPEAN CAUCASIAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POPULATION RESEARCH; PROSTATE CARCINOMA; SINGLE NUCLEOTIDE POLYMORPHISM; ETHNOLOGY; GENETIC POLYMORPHISM; GENETICS; HAPLOTYPE; NUCLEOTIDE SEQUENCE; PROSTATE TUMOR;

BASE SEQUENCE; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS;

EID: 68149163248     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006370     Document Type: Article

References (30)

1. Gomez-Zaera M, Abril J, Gonzalez L, Aguilo F, Condom E, et al. (2006) Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients. Mutat Res 595: 42-51.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
3. Warburg O (1956) On the origin of cancer cells. Science 123: 309-314.
4. Canter JA, Kallianpur AR, Parl FF, Millikan RC (2005) Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 65: 8028-8033.
5. Ballard JW, Whitlock MC (2004) The incomplete natural history of mitochondria. Mol Ecol 13: 729-744.
6. Taanman JW (1999) The mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta 1410: 103-123.
7. Wallace DC, Brown MD, Lott MT (1999) Mitochondrial DNA variation in human evolution and disease. Gene 238: 211-230.
8. Penta JS, Johnson FM, Wachsman JT, Copeland WC (2001) Mitochondrial DNA in human malignancy. Mutat Res 488: 119-133.
9. Torroni A, Wallace DC (1994) Mitochondrial DNA variation in human populations and implications for detection of mitochondrial DNA mutations of pathological significance. J Bioenerg Biomembr 26: 261-271.
10. Torroni A, Lott MT, Cabell MF, Chen YS, Lavergne L, et al. (1994) mtDNA and the origin of Caucasians: identification of ancient Caucasian-specific haplogroups, one of which is pron to a recurrent somatic duplication in the D-loop region. Am J Hum Genet 55: 760-776.
11. Torroni A, Huoponen K, Francalacci P, Petrozzi M, Morelli L, et al. (1996) Classification of European mtDNAs from an analysis of three European populations. Genetics 144: 1835-1850.
12. Brown MD, Torroni A, Reckord CL, Wallace DC (1995) Phylogenetic analysis of Leber's hereditary optic neuropathy mitochondrial DNA's indicates multiple independent occurrences of the common mutations. Hum Mutat 6: 311-325.
13. Brown MD, Sun F, Wallace DC (1997) Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am J Hum Genet 60: 381-387.
14. Kofler B, Mueller EE, Eder W, Stanger O, Maier R, et al. (2009) Mitochondrial DNA haplogroup T is associated with coronary artery disease and diabetic retinopathy: a case control study. BMC Med Genet 10: 35.
15. Darvishi K, Sharma S, Bhat AK, Rai E, Bamezai RN (2007) Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett 249: 249-255.
16. Xu L, Hu Y, Chen B, Tang W, Han X, et al. (2006) Mitochondrial polymorphisms as risk factors for endometrial cancer in southwest China. Int J Gynecol Cancer 16: 1661-1667.
17. Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ (2007) Mitochondrial genetic background modifies breast cancer risk. Cancer Res 67: 4687-4694.
18. Booker LM, Habermacher GM, Jessie BC, Sun QC, Baumann AK, et al. (2006) North American white mitochondrial haplogroups in prostate and renal cancer. J Urol 175: 468-472; discussion 472-463.
19. Abril J, de Heredia ML, Gonzalez L, Cleries R, Nadal M, et al. (2008) Altered expression of 12S/MT-RNR1, MT-CO2/COX2, and MT-ATP6 mitochondrial genes in prostate cancer. Prostate 68: 1086-1096.
20. Wiesbauer M, Meierhofer D, Mayr JA, Sperl W, Paulweber B, et al. (2006) Multiplex primer extension analysis for rapid detection of major European mitochondrial haplogroups. Electrophoresis 27: 3864-3868.
21. Brandstatter A, Parsons TJ, Parson W (2003) Rapid screening of mtDNA coding region SNPs for the idenification of west European Caucasian haplogroups. Int J Legal Med 117: 291-298.
22. Pereira L, Goncalves J, Goios A, Rocha T, Amorim A (2005) Human mtDNA haplogroups and reduced male fertility: real association or hidden population substructuring. Int J Androl 28: 241-247.
23. Dubut V, Chollet L, Murail P, Cartault F, Beraud-Colomb E, et al. (2004) mtDNA polymorphisms in five French groups: importance of regional sampling. Eur J Hum Genet 12: 293-00.
24. Canter JA, Kallianpur AR, Fowke JH (2006) Re: North American white mitochondrial haplogroups in prostate and renal cancer. J Urol 176: 2308-2309. author reply 2309.
25. Kim W, Yoo TK, Shin DJ, Rho HW, Jin HJ, et al. (2008) Mitochondrial DNA haplogroup analysis reveals no association between the common genetic lineages and prostate cancer in the Korean population. PLoS ONE 3: e2211.
26. Samuels DC, Carothers AD, Horton R, Chinnery PF (2006) The power to detect disease associations with mitochondrial DNA haplogroups. Am J Hum Genet 78: 713-720.
27. Chen JZ, Gokden N, Greene GF, Mukunyadzi P, Kadlubar FF (2002) Extensive somatic mitochondrial mutations in primary prostate cancer using laser capture microdissection. Cancer Res 62: 6470-6474.
28. Taylor RW, Turnbull DM (2005) Mitochondrial DNA mutations in human disease. Nat Rev Genet 6: 389-402.
29. Oberaigner W, Horninger W, Klocker H, Schonitzer D, Stuhlinger W, et al. (2006) Reduction of prostate cancer mortality in Tyrol, Austria, after introduction of prostate-specific antigen testing. Am J Epidemiol 164: 376-384.
30. Bartsch G, Horninger W, Klocker H, Pelzer A, Bektic J, et al. (2008) Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality. BJU Int 101: 809-816.